The vector of anti-CD20 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD20. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CD20 antibody linked to CD28 signaling domains. And the vector product was designed for the treatment of CD22+malignancies, B-cell lymphoma, mantle cell lymphoma, CD20+ diffuse large cell lymphoma (DLCL), leukemias.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|DMAb-1607-CQ||Rabbit Anti-MS4A1 DNA-encoded mAb (Clone IGEL/1497R), pVAX1|
|DMAb-1049-WJ||Mouse Anti-MS4A1 DNA-encoded mAb (Clone CBWJC-2331), pVAX1|
|CAR-WFY5661||Anti-MS4A1 (CBFYM-0245) h(CD28-CD3ζ) CAR, pCDCAR1|
|DMAb-1071-WJ||Mouse Anti-MS4A1 DNA-encoded mAb (Clone CBWJC-4173), pVAX1|
|DMAb-2404-FY||Rabbit Anti-MS4A1 DNA-encoded mAb (CBFYM-0025), pVAX1|
|CAR-WFY2410||Anti-MS4A1 (CBFYM-0329) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-WFY5665||Anti-MS4A1 (CBFYM-0359) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-WJ1063||Anti-MS4A1 (AT80) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-CQ5023||Anti-MS4A1 (CBXC-2342) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ1594||Anti-MS4A1 (CBXC-0875) h(41BB-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved